Stock MYNZ MAINZ BIOMED N.V.
Add to a list
To use this feature you must be a member
Log inSign up

Company Mainz Biomed N.V.

Equities

MYNZ

NL0015000LC2

Healthcare Facilities & Services

Real-time Estimate Cboe BZX
Other stock markets
 03:41:41 2024-04-19 pm EDT 		5-day change 1st Jan Change
0.89 USD -1.55% Intraday chart for Mainz Biomed N.V. -9.27% -24.13%
Apr. 09 Mainz Biomed N.V. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 05 Mainz Biomed N.V. Partners with Trusted Health Advisors to Support U.S. Go-To-Market Strategy for Next Generation Early Colorectal Cancer Diagnostic CI

Business Summary

Mainz Biomed B.V. is a Germany based molecular genetics cancer diagnostic company. The Company operates under one segment, namely genetic diagnostic testing services. Its portfolio consists of various products and product candidates, such as ColoAlert, a colorectal cancer (CRC) screening stool-based DNA (deoxyribonucleic acid) test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoStrip, a platform technology to detect pathogens in environments on a molecular genetic basis. The Company competes with Exact Sciences, Epigenomics AG, Novigenix SA, GRAIL, Inc. and Agena Biosciences Inc.

Number of employees: 68

Sales per Business

USD in Million2022Weight2023Weight Delta
Genetic Diagnostic Testing
100.0 %
1 100.0 % 1 100.0 % +69.00%

Sales per region

USD in Million2022Weight2023Weight Delta
Germany
100.0 %
1 100.0 % 1 100.0 % +69.00%

Managers

Managers TitleAgeSince
Guido Baechler CEO
 Chief Executive Officer 59 21-06-30
William Caragol DFI
 Director of Finance/CFO 58 21-06-30
Corinna Gorges CTO
 Chief Tech/Sci/R&D Officer - 21-10-31
Frank Krieg-Schneider CTO
 Chief Tech/Sci/R&D Officer - 22-08-02
Moritz Eidens CTO
 Chief Tech/Sci/R&D Officer 41 -
Stefan Erlach HRO
 Human Resources Officer - -
Amy Levin LAW
 General Counsel - 22-11-28
Jane Edwards PRN
 Corporate Officer/Principal - 22-06-13
Steve Quinn PRN
 Corporate Officer/Principal - 22-01-26
Philipp Freese PRN
 Corporate Officer/Principal 42 15-01-31

Members of the board

Members of the board TitleAgeSince
Gregory Tibbitts BRD
 Director/Board Member 57 22-12-13
Heiner Dreismann CHM
 Chairman 69 22-12-13
Hans Johan Hekland BRD
 Director/Board Member 66 21-10-31
Guido Baechler CEO
 Chief Executive Officer 59 21-06-30
Moritz Eidens CTO
 Chief Tech/Sci/R&D Officer 41 -
Nicole Holden BRD
 Director/Board Member 51 21-10-31
Alberto Libanori BRD
 Director/Board Member 35 21-10-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 21,886,575 18,256,212 ( 83.41 %) 0 83.41 %

Shareholders

NameEquities%Valuation
Government of Germany
7.389 %
1,237,501 7.389 % 1 M $
Hans Johan Hekland
6.696 %
1,121,427 6.696 % 1 M $
Moritz Eidens
5.318 %
890,652 5.318 % 917 372 $
Guido Baechler
1.520 %
254,507 1.520 % 262 142 $
Philipp Freese
0.7540 %
126,276 0.7540 % 130 064 $
Prelude Capital Management LLC
0.4478 %
75,000 0.4478 % 77 250 $
Citadel Securities GP LLC
0.1985 %
33,244 0.1985 % 34 241 $
Northern Trust Global Investments Ltd.
0.1975 %
33,082 0.1975 % 34 074 $
Morgan Stanley Capital Services LLC
0.1913 %
32,045 0.1913 % 33 006 $
Geode Capital Management LLC
0.0907 %
15,189 0.0907 % 15 645 $

Company contact information

Mainz Biomed NV

Sirius Gutenberg Park Robert Koch Strasse 50

55129, Mainz

+49 6131 554 2860

http://mainzbiomed.com
address Mainz Biomed N.V.(MYNZ)

Sector

Healthcare
Healthcare Services
Healthcare Providers & Services
Healthcare Facilities & Services
Medical & Diagnostic Laboratories

Ratings for Mainz Biomed N.V.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
0.904 USD
Average target price
2 USD
Spread / Average Target
+121.24%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

1st Jan change Capi.
MAINZ BIOMED N.V. Stock Mainz Biomed N.V.
-24.13% 19.79M
SONIC HEALTHCARE LIMITED Stock Sonic Healthcare Limited
-18.11% 8.02B
RADNET, INC. Stock RadNet, Inc.
+33.19% 3.51B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. Stock Guangzhou Kingmed Diagnostics Group Co., Ltd.
-29.02% 2.97B
SYNLAB AG Stock SYNLAB AG
-7.71% 2.48B
DR. LAL PATHLABS LIMITED Stock Dr. Lal PathLabs Limited
-14.30% 2.23B
NEOGENOMICS, INC. Stock NeoGenomics, Inc.
-16.56% 1.76B
FLEURY S.A. Stock Fleury S.A.
-22.62% 1.44B
DIAN DIAGNOSTICS GROUP CO.,LTD. Stock Dian Diagnostics Group Co.,Ltd.
-39.69% 1.25B
ADICON HOLDINGS LIMITED Stock Adicon Holdings Limited
-11.20% 1.11B
Medical & Diagnostic Laboratories
  1. Stock Market
  2. Equities
  3. MYNZ Stock
  4. Company Mainz Biomed N.V.